Staphylococcus aureus Bloodstream Infections:Clinical Characteristics and Resistance Analysis

YANG Le-he,YU Fang-you,HE Su-su,LI Qiao-qiao,ZHANG Xue-qing,YAO Dan,WANG Liang-xing
2010-01-01
Abstract:OBJECTIVE To investigate the clinical characteristics and resistance of Staphylococcus aureus bloodstream infections so as to guide the treatment of S.aureus bloodstream infections.METHODS Clinical data of S.aureus bloodstream infections were collected and drug sensitivity of isolated strains to antibacterial agents was tested.RESULTS Among 87 cases with S.aureus bloodstream infections,severe underlying diseases existed in 66 cases.Eighty-seven strains of S.aureus were isolated,including 36 meticillin-resistant S.aureus(MRSA)(41.4%),strains S.aureus showed general resistance to many kinds of antibiotic drugs.The resistant rates to penicillin and ampicillin/sulbactam were higher than 95.0%,while only the resistant rates to sulfamethoxazole/trimethoprim and rifampicin were lower than 20.0%.All isolates of S.aureus were 100.0% sensitive to vancomycin,linezolid,teicoplanin and quinupristin/dalfopristin.The resistant rates of MRSA to ampicillin/subactam,sulfamethoxazole/trimethoprim,erythromycin,clindamycin hydrochloride,rifampicin,gentamicin,tetracycline and levofloxacin were all significantly higher than those of MSSA.CONCLUSION S.aureus bloodstream infections usually occur in the patients with severe underlying diseases.MRSA shows multi-resistant characteristics,but still keeps highly sensitive to vancomycin,linezolid,teicoplanin and quinupristin/dalfopristin.
What problem does this paper attempt to address?